IVZ
62
-3
FCX
54
-16
GPC
40
-3
CVS
41
2
MCHP
59
-3
IP
65
3
WBA
38
3
CFG
52
-4
DE
30
-10
FMC
36
2
IFF
56
-12
DO
83
2
MRO
40
-2
HAL
47
3
PNR
65
-4
BIIB
48
-3
TROW
59
-2
BMY
33
-2
ZTS
65
2
CLX
50
4
IVZ
62
-3
FCX
54
-16
GPC
40
-3
CVS
41
2
MCHP
59
-3
IP
65
3
WBA
38
3
CFG
52
-4
DE
30
-10
FMC
36
2
IFF
56
-12
DO
83
2
MRO
40
-2
HAL
47
3
PNR
65
-4
BIIB
48
-3
TROW
59
-2
BMY
33
-2
ZTS
65
2
CLX
50
4
Financhill
Back

Sarepta Therapeutics Vs. Regenxbio Industry Stock Comparison

Sell
50

SRPT
Sarepta Therapeutics

Last Price:
131.39
Seasonality Move:
8.89%
Sell
41

RGNX
Regenxbio

Last Price:
15.98
Seasonality Move:
7.34%
Sell
50
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $132.74. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $16.01. The Score for RGNX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $132.74
    The current trend is moderately bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $16.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing slight selling pressure.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.32 Buy
Relative Strength Index (14 RSI): 60.57 Buy
Chaikin Money Flow: 825203 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (120.05 - 133.59) Buy
Bollinger Bands (100): (112.21 - 133.05) Buy

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 41.05 Sell
Chaikin Money Flow: -33087 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.62 - 17.08) Sell
Bollinger Bands (100): (14.57 - 20.71) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 132.8 Sell
20-day SMA: 128.89 Buy
50-day SMA: 126.17 Buy
200-day SMA: 113.39 Buy
8-day EMA: 132.23 Buy
20-day EMA: 130 Buy
50-day EMA: 126.73 Buy
200-day EMA: 118.1 Buy

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.07 Sell
20-day SMA: 16.1 Sell
50-day SMA: 18.81 Sell
200-day SMA: 17.63 Sell
8-day EMA: 16.06 Sell
20-day EMA: 16.51 Sell
50-day EMA: 17.52 Sell
200-day EMA: 18.25 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.06 per share, an increase next quarter of $1.31 per share, an increase this year of $6.16 per share, and an increase next year of $6.01 per share.

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $2.06 per share, an increase this year of $0.57 per share, and an increase next year of $2.96 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):